Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 P373 | DOI: 10.1530/endoabs.81.P373

Mohammed VI University Hospital, Department of Endocrinology, Diabetes, Metabolic diseases and Nutrition, Marrakech, Morocco


Introduction: The association of multi-organ autoimmune diseases is described. We report a case of association between Latent autoimmune diabetes in adults (LADA) and systemic scleroderma (SSc), which remains a rarely reported entity in the literature.

Observation: 38-year-old female patient, followed for systemic scleroderma with digestive and pulmonary involvements. The patient presented a dysphagia to solids with dyspnea installed in the last 2 months, with general state alteration. No polyuro-polydipsic syndrome, no diabetic heredity. A generalized cutaneous sclerosis was objectified at the clinical examination. A standard workup showed fasting blood glucose at 1.69 g/l with HbA1c: 8.6%, the patient is treated with insulin-therapy. Immunology typing test of diabetes: anti GAD, anti Znt8: positive Skin biopsy: Morphological aspect compatible with scleroderma.

Discussion: Cases of coexistence of autoimmune diabetes with systemic sclerosis are rare. The pathogenesis of this association is not yet well understood. Interferon seems to play a major role as an immunomodulator and inhibitor of collagen production, and hypotheses suggest that it is also involved in the pathophysiology of several autoimmune diseases, including diabetes. And it is well known that autoimmune diseases with the presence of organ-specific antibodies such as autoimmune diabetes or autoimmune thyroiditis can coexist with other non-organ-specific autoimmune diseases such as SSc. In addition, autoimmune diabetes has been shown to be more likely to occur in first-degree relatives of patients with SSc.

Conclsion: The association of autoimmune diabetes and systemic scleroderma could be at the origin of a difficulty to assure insulin injections, which may be responsible for an important blood glucose unbalance.

Bibliography: 1. Divaker Choubey, Interferons in Autoimmune and Inflammatory Diseases: Regulation and Roles. JOURNAL OF INTERFERON & CYTOKINE RESEARCH Volume 31, Number 12, 2011 2. Caterina Ferreli1, Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Clinic Rev Allerg Immunol 3. Yannick Allanore, Physiopathologie de la sclárodermie systámique. medecine/sciences 2016; 32: 83–91 4. Ewa Wielosz1, Coexistence of diabetes mellitus type 1 with diffuse systemic sclerosis: case report and literature review. Reumatologia 2017;55(2): 104–107 5. Koumakis E, Dieude P, Avouac J, et al. Familial autoimmunity in systemic sclerosis- results of a French-based case controlfamily study. J Rheumatol 2012; 39: 532–538. 6.Hála Zeglaoui, Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl. Rheumatol Int (2010) 30:793–795

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.